Notes / Company

Themis Medicare Ltd.

THEMISMED BSE 530199 ISIN INE083B01024 Pharmaceuticals

Fundamentals

Market cap: ₹1,049 cr
ROE: 7.41%
Debt / equity: 0.21
Div yield: 0.44%
52-week range: 64.95 — 154.72

The timeline — 1 note on Themis Medicare Ltd.

May 2026

28 May 26 · 1:53 PM IST Brief

Brief · Earnings · Small cap

Themis Medicare profit drops 96% to ₹1.14 crore

The pharmaceutical company reported a sharp decline in annual net profit for FY26, down from ₹29.83 crore in the prior year.

Verify on exchange BSE filings for THEMISMED NSE filings for THEMISMED